{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:32:01Z","timestamp":1786120321761,"version":"build-2736575974"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"40","license":[{"start":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T00:00:00Z","timestamp":1759449600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,10,3]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>The motor and non-motor symptoms of PD severely impair the quality of life of PD patients. rTMS improves neuroplasticity by modulating cortical striatal pathways and provides a new strategy for non-pharmacological interventions, but its synergistic effect and optimal combination with pharmacological therapies have not been clarified. Meta-analysis was used to assess the clinical efficacy and safety of rTMS combined with pramipexole in the treatment of PD.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A comprehensive search was conducted in the CNKI, VIP, Wanfang, CBM, PubMed, Web of Science, and Cochrane Library databases for clinical randomized controlled trials (RCTs) on the combined use of rTMS and pramipexole for the treatment of PD. The literature was in Chinese and English. Researchers used the Cochrane risk of bias assessment tool to determine the quality of the included literature, as well as the GRADE to assess the quality of the data. The primary outcome measure was the UPDRS, and the secondary outcome measures were: HAMD, FAQ, STEF, BBS, MAS, MMSE, MoCA, PDSS, PDQ-39, NMSQuest, SCOPA-AUT, Adverse Event Rate. The analysis of autonomic nervous system function used a random effects model, while the rest used a fixed-effects model. Furthermore, we performed trial sequential analysis. Due to the small sample size, sensitivity analysis was performed by excluding individual RCTs 2 by 1.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      Twelve studies, all RCTs, ultimately included 995 patients. Meta-analysis results showed: rTMS combined with pramipexole had a higher overall effective rate in treating PD patients than the control group, and significantly reduced the UPDRS total score (OR\u2005=\u20054.58, 95% CI: 2.91\u20137.19,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001). Based on our validation through trial sequential analysis, this result is decisive and robust. rTMS with pramipexole treatment showed overall improvement in PD (OR\u2005=\u20054.58, 95% CI: 2.91\u20137.19,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001), improvement in cognitive functioning (MD\u2005=\u20052.23, 95% CI: 1.91\u20132.54,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001), improvement in depression level (MD\u2005=\u2005\u22122.22, 95% CI: \u22122.71 to \u22121.72,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001), improvement in social functioning (MD\u2005=\u2005\u22122.64, 95% CI: \u22123.09 to \u22122.19,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001), improvement in non-motor symptoms (MD\u2005=\u2005\u22121.29, 95% CI: \u22121.97 to \u22120.60,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0002), gait improvement (MD\u2005=\u20056.34, 95% CI: 2.66\u201310.02,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001; MD\u2005=\u20054.59, 95% CI: 2.37\u20136.80,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.0001; MD\u2005=\u2005\u20130.14, 95% CI: \u20130.19 to \u22120.09,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005&lt;\u2005.00001) and other significant efficacy. Safety analysis showed that the rTMS combined with pramipexole group had a lower incidence of adverse effects during treatment (OR\u2005=\u20050.77, 95% CI: 0.40\u20131.46,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.42). The GRADE assessment showed two outcomes as moderate-quality evidence, 6 as low-quality evidence, and 3 as very-low-quality evidence. In terms of heterogeneity analyses, the heterogeneity of the analyses was relatively low, except for significant heterogeneity in autonomic function and sleep quality. Also, funnel plot analyses were performed without significant publication bias.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>rTMS combined with pramipexole treatment can significantly control the symptoms of PD, accelerate the healing of the disease, better than the single pramipexole treatment of the clinical effect, and the safety of the use of the drug is higher.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000044793","type":"journal-article","created":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T20:06:10Z","timestamp":1759781170000},"page":"e44793","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":2,"title":["Meta-analysis of the therapeutic effect and safety of repetitive transcranial magnetic stimulation combined with pramipexole in Parkinson\u2019s disease"],"prefix":"10.1097","volume":"104","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-9725-2521","authenticated-orcid":false,"given":"Jinyu","family":"Geng","sequence":"first","affiliation":[{"name":"The First Clinical Medical College of Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaobei","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Neurology, The Second Affiliated Hospital of Xinjiang Medical University, Urumqi, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiawei","family":"Ren","sequence":"additional","affiliation":[{"name":"The First Clinical Medical College of Xinjiang Medical University, Urumqi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260526","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1186\/s12883-024-03990-9","article-title":"Repetitive transcranial magnetic stimulation improves cognition, depression, and walking ability in patients with Parkinson\u2019s disease: a meta-analysis.","volume":"24","author":"Wang","year":"2024","journal-title":"BMC Neurol"},{"key":"R2-20260526","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10143-025-03206-9","article-title":"Delirium after deep brain stimulation for Parkinson\u2019s disease: a meta-analysis of incidence and risk factors.","volume":"48","author":"Yousef","year":"2025","journal-title":"Neurosurg Rev"},{"key":"R3-20260526","first-page":"124","article-title":"Interpretation of diagnostic criteria for Parkinson\u2019s disease in China.","volume":"37","author":"Chen","year":"2017","journal-title":"Chin J Pract Internal Med"},{"key":"R4-20260526","doi-asserted-by":"crossref","first-page":"e0313420","DOI":"10.1371\/journal.pone.0313420","article-title":"Unveiling the efficacy of repetitive transcranial magnetic stimulation in Parkinson\u2019s disease: a comprehensive review of systematic analyses.","volume":"20","author":"Zhang","year":"2025","journal-title":"PLoS One"},{"key":"R5-20260526","first-page":"1362","article-title":"Efficacy of rTMS combined with pramipexole in the treatment of elderly patients with Parkinson\u2019s disease and its effect on gait indexes and serum S100\u03b2 NSE BDNF levels.","volume":"30","author":"Shi","year":"2024","journal-title":"Hebei Med"},{"key":"R6-20260526","doi-asserted-by":"crossref","first-page":"e40689","DOI":"10.1097\/MD.0000000000040689","article-title":"Efficacy of repetitive transcranial magnetic stimulation combined with peripheral magnetic stimulation on movement symptom and exploration of the optimal population in Parkinson\u2019s disease: A randomized controlled trial.","volume":"103","author":"Sun","year":"2024","journal-title":"Medicine (Baltim)"},{"key":"R7-20260526","first-page":"186","article-title":"Efficacy of repetitive transcranial magnetic stimulation combined with pramipexole in the treatment of combined depression in middle to advanced Parkinson\u2019s disease.","volume":"42","author":"Qin","year":"2024","journal-title":"J Guangdong Med Univ"},{"key":"R8-20260526","first-page":"161","article-title":"Effectiveness of low-frequency repetitive transcranial magnetic stimulation combined with pramipexole in the treatment of Parkinson\u2019s disease and its effect on non-motor symptoms and muscle tone.","volume":"16","author":"Ma","year":"2023","journal-title":"Clin Rat Use Drugs"},{"key":"R9-20260526","first-page":"57","article-title":"Evaluation of the efficacy of repetitive transcranial magnetic stimulation combined with pramipexole in the treatment of Parkinson\u2019s in the elderly.","volume":"20","author":"Li","year":"2022","journal-title":"China Geriatric Health Care Med"},{"key":"R10-20260526","first-page":"592","article-title":"Clinical efficacy of pramipexole combined with high-frequency repetitive transcranial magnetic stimulation in the treatment of patients with early Parkinson\u2019s disease combined with depression.","volume":"23","author":"Dai","year":"2021","journal-title":"Southeast Defense Med"},{"key":"R11-20260526","first-page":"88","article-title":"Effects of low-frequency repetitive transcranial magnetic stimulation combined with pramipexole on non-motor symptoms and oxidative stress indexes in Parkinson\u2019s patients.","volume":"6","author":"Shao","year":"2021","journal-title":"Clin Med Res Pract"},{"key":"R12-20260526","first-page":"39","article-title":"Efficacy of low-frequency repetitive transcranial magnetic stimulation combined with pramipexole in the treatment of early-stage Parkinson\u2019s patients.","volume":"44","author":"Guo","year":"2021","journal-title":"Heilongjiang Med Sci"},{"key":"R13-20260526","first-page":"145","article-title":"The efficacy of low-frequency repetitive transcranial magnetic stimulation combined with pramipexole in the treatment of Parkinson\u2019s disease.","volume":"41","author":"Qiao","year":"2020","journal-title":"J Med Forum"},{"key":"R14-20260526","first-page":"2573","article-title":"Effect of pramipexole hydrochloride extended-release tablets combined with high-frequency repetitive transcranial magnetic stimulation in the treatment of Parkinson\u2019s disease.","volume":"28","author":"Wang","year":"2019","journal-title":"Henan Med Res"},{"key":"R15-20260526","first-page":"312","article-title":"Efficacy of pramipexole hydrochloride combined with high-frequency repetitive transcranial magnetic stimulation in the treatment of Parkinson\u2019s dementia and its effects on patients\u2019 cognitive function and serum CRP and PARK7.","volume":"13","author":"Zhu","year":"2018","journal-title":"Intern Med"},{"key":"R16-20260526","first-page":"8","article-title":"Effects of repetitive transcranial magnetic stimulation combined with pramipexole on autonomic function in patients with Parkinson\u2019s disease.","volume":"5","author":"Qin","year":"2023","journal-title":"Chin Sci Technol J Database (Full Text Edition) Med Health"},{"key":"R17-20260526","first-page":"52","article-title":"A controlled study of pramipexole hydrochloride extended-release tablets combined with rTMS in the treatment of Parkinson\u2019s disease.","volume":"25","author":"Song","year":"2019","journal-title":"J Clin Psychosomatic Diseases"},{"key":"R18-20260526","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1080\/17568919.2024.2444875","article-title":"The design and development of LRRK2 inhibitors as novel therapeutics for Parkinson\u2019s disease.","volume":"17","author":"Bai","year":"2025","journal-title":"Future Med Chem"},{"key":"R19-20260526","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1186\/s13063-024-08385-2","article-title":"Efficacy of personalized repetitive transcranial magnetic stimulation based on functional reserve to enhance ambulatory function in patients with Parkinson\u2019s disease: study protocol for a randomized controlled trial.","volume":"25","author":"Yun","year":"2024","journal-title":"Trials"},{"key":"R20-20260526","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1002\/acn3.52183","article-title":"Cerebellar transcranial magnetic stimulationimproves motor function in Parkinson\u2019s disease.","volume":"11","author":"Grobe-Einsler","year":"2024","journal-title":"Ann Clin Transl Neurol"},{"key":"R21-20260526","doi-asserted-by":"crossref","first-page":"14219","DOI":"10.1038\/s41598-024-64196-0","article-title":"Assessment of noninvasive brain stimulation interventions in Parkinson\u2019s disease: a systematic review and network meta-analysis.","volume":"14","author":"Wang","year":"2024","journal-title":"Sci Rep"},{"key":"R22-20260526","doi-asserted-by":"crossref","first-page":"769","DOI":"10.62641\/aep.v52i6.1711","article-title":"The combined use of levodopa\/benserazide and pramipexole proves beneficial for managing Parkinson\u2019s disease.","volume":"52","author":"Liu","year":"2024","journal-title":"Actas Esp Psiquiatr"},{"key":"R23-20260526","first-page":"907","article-title":"Effects of pramipexole on mood and cognitive function in patients with Parkinson\u2019s disease.","volume":"51","author":"Qin","year":"2024","journal-title":"Int J Psychiatry"},{"key":"R24-20260526","first-page":"2106","article-title":"Meta-analysis of the efficacy and safety of dobasic hydrazide combined with pramipexole in the treatment of Parkinson\u2019s disease.","volume":"18","author":"Zhang","year":"2020","journal-title":"Chin Family Med"},{"key":"R25-20260526","first-page":"8448584","article-title":"A systematic review and meta-analysis of the efficacy and safety of rasagiline or pramipexole in the treatment of early Parkinson\u2019s Disease.","volume":"2024","author":"Sepp\u00e4nen","year":"2024","journal-title":"Parkinsons Dis"},{"key":"R26-20260526","doi-asserted-by":"crossref","first-page":"100452","DOI":"10.1016\/j.ijchp.2024.100452","article-title":"Efficacy and safety of repetitive Transcranial Magnetic Stimulation and transcranial Direct Current Stimulation in memory deficits in patients with Alzheimer\u2019s disease: meta-analysis and systematic review.","volume":"24","author":"Fernandes","year":"2024","journal-title":"Int J Clin Health Psychol"},{"key":"R27-20260526","first-page":"140","article-title":"Evaluation of the effect of dopamine receptor agonist pramipexole in the treatment of non-motor symptoms in Parkinson\u2019s disease.","volume":"42","author":"Ye","year":"2023","journal-title":"Chin Foreign Med Treatment"},{"key":"R28-20260526","first-page":"601","article-title":"Application of transcranial magnetic stimulation in the study of pathophysiology and treatment of Parkinson\u2019s disease.","volume":"52","author":"Wang","year":"2019","journal-title":"Chin J Neurol"},{"key":"R29-20260526","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.biopha.2016.04.026","article-title":"Dehpour AR Antidepressant effect of pramipexole in mice forced swimming test: Across talk between dopamine receptor and NMDA\/nitric oxide\/cGMP pathway.","volume":"81","author":"Ostadhadi","year":"2016","journal-title":"Biomed Pharmacother"},{"key":"R30-20260526","first-page":"312","article-title":"The efficacy of repetitive transcranial magnetic stimulation combined with psychological intervention in treating depressed patients with Parkinson\u2019s disease.","volume":"45","author":"Xiong","year":"2023","journal-title":"Chin J Phys Med Rehabil"},{"key":"R31-20260526","first-page":"52","article-title":"The efficacy of repetitive transcranial magnetic stimulation with pramipexole in the treatment of patients with Parkinson\u2019s disease.","volume":"3","author":"Pu","year":"2024","journal-title":"Chin Foreign Med Res"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044793","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T20:30:39Z","timestamp":1786048239000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0000000000044793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,3]]},"references-count":31,"journal-issue":{"issue":"40","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000044793","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,3]]},"assertion":[{"value":"2025-06-02","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2025-09-02","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}